100000 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 100020 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details) 2 link:presentationLink link:calculationLink link:definitionLink 100030 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 100040 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 100050 - Statement - Consolidated Statements of Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 100060 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 100070 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 995455 - Disclosure - Cybersecurity Risk Management, Strategy, and Governance link:presentationLink link:calculationLink link:definitionLink 995465 - Disclosure - Organization, Basis of Presentation and Liquidity link:presentationLink link:calculationLink link:definitionLink 995475 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 995485 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 995495 - Disclosure - Marketable Securities link:presentationLink link:calculationLink link:definitionLink 995505 - Disclosure - Property and Equipment, Net link:presentationLink link:calculationLink link:definitionLink 995515 - Disclosure - Goodwill and Intangible Assets, Net link:presentationLink link:calculationLink link:definitionLink 995525 - Disclosure - Accounts Payable and Accrued Liabilities link:presentationLink link:calculationLink link:definitionLink 995535 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 995545 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 995555 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 995565 - Disclosure - Stock-Based Awards link:presentationLink link:calculationLink link:definitionLink 995575 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 995585 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 995595 - Disclosure - Employee Benefit Plan link:presentationLink link:calculationLink link:definitionLink 995605 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 995615 - Disclosure - Enterprise-Wide Disclosures link:presentationLink link:calculationLink link:definitionLink 995625 - Disclosure - Selected Quarterly Financial Information link:presentationLink link:calculationLink link:definitionLink 995635 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 995645 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 995655 - Disclosure - Organization, Basis of Presentation and Liquidity (Tables) link:presentationLink link:calculationLink link:definitionLink 995665 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 995675 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 995685 - Disclosure - Marketable Securities (Tables) link:presentationLink link:calculationLink link:definitionLink 995695 - Disclosure - Property and Equipment, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995705 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 995715 - Disclosure - Accounts Payable and Accrued Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 995725 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 995735 - Disclosure - Stock-Based Awards (Tables) link:presentationLink link:calculationLink link:definitionLink 995745 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 995755 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 995765 - Disclosure - Enterprise-Wide Disclosures (Tables) link:presentationLink link:calculationLink link:definitionLink 995775 - Disclosure - Selected Quarterly Financial Information (Tables) link:presentationLink link:calculationLink link:definitionLink 995785 - Disclosure - Organization, Basis of Presentation and Liquidity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995795 - Disclosure - Schedule of Lineage’s Ownership of Outstanding Shares of its Subsidiaries (Details) link:presentationLink link:calculationLink link:definitionLink 995805 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995815 - Disclosure - Significant Accounting Policies - Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 995825 - Disclosure - Revenue - Schedule of Disaggregated Revenues (Details) link:presentationLink link:calculationLink link:definitionLink 995835 - Disclosure - Revenue - Schedule of Disaggregated Revenues (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995845 - Disclosure - Revenue - Schedule of Contract with Customer Contract Liability and Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 995855 - Disclosure - Revenue - Schedule of Contract with Customer Contract Liability and Receivable (Parenthetical) (Details) link:presentationLink link:calculationLink link:definitionLink 995865 - Disclosure - Revenue - Schedule of Collaboration Agreements (Details) link:presentationLink link:calculationLink link:definitionLink 995875 - Disclosure - Revenue - Schedule of Collaboration Agreements (Details) (Paranthetical) link:presentationLink link:calculationLink link:definitionLink 995885 - Disclosure - Revenue - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995895 - Disclosure - Marketable Securities - Schedule of Fair Value of Marketable Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995905 - Disclosure - Marketable Securities - Summary of Available for Sale Debt Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995915 - Disclosure - Marketable Securities - Schedule of Amortized Cost and Estimated Fair Value of Available-for-sale Debt Securities by Contractual Maturity (Details) link:presentationLink link:calculationLink link:definitionLink 995925 - Disclosure - Marketable Securities - Schedule of Marketable Equity Securities (Details) link:presentationLink link:calculationLink link:definitionLink 995935 - Disclosure - Marketable Equity Securities - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995945 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) link:presentationLink link:calculationLink link:definitionLink 995955 - Disclosure - Property and Equipment, Net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995965 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets Net (Details) link:presentationLink link:calculationLink link:definitionLink 995975 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill and Intangible Assets Net (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 995985 - Disclosure - Goodwill and Intangible Assets, Net - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 995995 - Disclosure - Accounts Payable and Accrued Liabilities - Schedule of Accounts Payable and Accrued Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996005 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 996015 - Disclosure - Fair Value Measurements - Summary of Changes to Level 3 Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink 996025 - Disclosure - Fair Value Measurements - Significant Assumptions Used in Valuing the Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996035 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996045 - Disclosure - Related Party Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996055 - Disclosure - Shareholders' Equity - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996065 - Disclosure - Stock-Based Awards - Schedule of Share-based Compensation Activity (Details) link:presentationLink link:calculationLink link:definitionLink 996075 - Disclosure - Stock-Based Awards - Schedule of Weighted Average Assumptions to Calculate Fair Value of Stock Options (Details) link:presentationLink link:calculationLink link:definitionLink 996085 - Disclosure - Stock-Based Awards - Schedule of Stock Based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink 996095 - Disclosure - Stock-Based Awards - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996105 - Disclosure - Income Taxes - Schedule of Income before Income Tax, Domestic and Foreign (Details) link:presentationLink link:calculationLink link:definitionLink 996115 - Disclosure - Income Taxes - Schedule of Income Tax Rate Reconciliation (Details) link:presentationLink link:calculationLink link:definitionLink 996125 - Disclosure - Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 996135 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits Roll Forward (Details) link:presentationLink link:calculationLink link:definitionLink 996145 - Disclosure - Income Taxes - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996155 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Cash Flow Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 996165 - Disclosure - Commitments and Contingencies - Schedule of Supplemental Balance Sheet Information Related to Leases (Details) link:presentationLink link:calculationLink link:definitionLink 996175 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Commitments (Details) link:presentationLink link:calculationLink link:definitionLink 996185 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996195 - Disclosure - Employee Benefit Plan - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996205 - Disclosure - Segment Information - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 996215 - Disclosure - Enterprise-Wide Disclosures - Schedule of Geographic Area Information (Details) link:presentationLink link:calculationLink link:definitionLink 996225 - Disclosure - Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Details) link:presentationLink link:calculationLink link:definitionLink 996235 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink Maturities of marketable debt securities Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale, Total Statement [Line Items] H.C. Wainwright & Co., LLC [Member] H.C. Wainwright & Co., LLC. Cybersecurity Risk Board of Directors Oversight [Text Block] Increase (Decrease) in Accounts Receivable Accounts receivable Plan Name [Domain] Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Entity Address, Postal Zip Code Cell Cure [Member] Cell Cure [Member] Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Remaining performance obligations Revenue, Remaining Performance Obligation, Amount Fair Value, Recurring and Nonrecurring [Table] Entity Incorporation, State or Country Code Total lease payments Total lease payments Finance Lease, Liability, to be Paid Warrants Under Registered Direct Financing [Member] Warrants under registered direct financing. Expensed Issuance Cost For Common Stock Warrant Liabilities Expensed issuance cost for common stock warrant liabilities Issuance costs for common stock warrant liabilities Revenues [Abstract] Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Derivative Liability, Measurement Input Measurement input Roche [Member] Roche [Member] Number of operating segments Number of Operating Segments RSUs Vest On or Prior to March 9, 2023 [Member] Share-Based Payment Arrangement, Tranche One [Member] First tranche [Member] Research and development and other credits Effective Income Tax Rate Reconciliation, Tax Credit, Percent, Total Effective Income Tax Rate Reconciliation, Tax Credit, Percent Research and development and other credits Royalties, License and Other Revenues [Member] Royalties, License and Other Revenues [Member] Royalties, license and other revenues. Weighted Average Exercise Price of Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Finance leases, Accumulated amortization Finance Lease, Right-of-Use Asset, Accumulated Amortization Balance, shares Balance, shares Shares, Outstanding Fair Value Hierarchy and NAV [Axis] Auditor Name Fair Value, Inputs, Level 2 [Member] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] License Agreement [Member] License Agreement [Member] Roche and Immunomic Therapeutics Collaboration Agreement [Member] Roche and Immunomic Therapeutics Collaboration Agreement [Member] Percentage Of Management Fee Of Aggregate Gross Proceeds Percentage of management fee of aggregate gross proceeds. Percentage of management fee of aggregate gross proceeds Reductions related to a lapse of statute Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations Employees and officers'stock options Employees And Officers Stock Options[Member] Employees and officers stock options. Number Of Clinical Trials Number of clinical trials. Number of clinical trials Tax Credit Carryforward, Name [Domain] Combined purchase price of common stock and warrants Combined Purchase Price Of Common Stock And Warrants Combined purchase price of common stock and warrants. Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Summary of Changes to Level 3 Fair Value Measurement Product and Service [Axis] Deferred Income Tax Liabilities, Net Deferred tax liability Warrants And Rights Expiry Date Warrants and rights expiry date. Warrants and rights expiry date Intangible assets Fair value of intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Finite-Lived Intangible Assets by Major Class [Axis] Patents and licenses Deferred Tax Asset Parents and Licenses. Investment, Name [Domain] Share-based compensation stock option vesting percentage Share-based compensation stock option vested Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Net operating losses expiration date Net operating losses expiration date. Net operating loss carryforwards expiration description Effective Income Tax Rate Reconciliation, GILTI, Amount Collaborative Arrangement and Arrangement Other than Collaborative [Domain] SUPPLEMENTAL SCHEDULE OF NON-CASH FINANCING AND INVESTINGACTIVITIES: Noncash Investing and Financing Items [Abstract] Deposits and Other Long-Term Assets [Member] Deposits and Other Long-Term Assets [Member] Deposits and Other Long-Term Assets [Member] Investment owned, at fair value Investment Owned, Fair Value, Ending Balance Investment Owned, Fair Value, Beginning Balance Investment Owned, Fair Value Cybersecurity Risk Management Processes Integrated [Text Block] Shareholders' Equity Equity [Text Block] Fair value of warrant liability at issuance Fair Value Of Warrant Liability At Issuance Fair value of warrant liability at issuance. Title and Position [Axis] Royalties, license and other revenues. Royalties, license and other revenues Royalties, License and Other Revenues Federal net operating loss carryforwards offset percent of taxable income Federal Net Operating Loss Carryforwards Offset Percent Of Taxable Income Federal net operating loss carryforwards offset percent of taxable income. Revenue Revenue from Contract with Customer [Text Block] Unrealized loss on marketable equity securities related to changes in fair market value Marketable Security, Realized Gain (Loss) Sale of Stock [Domain] Cash and Cash Equivalents [Domain] Going Concern Assessment Going concern assessment Going concern [Policy Text Block] Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table Text Block] Schedule of Amortized cost and Estimated fair Value Financial Instrument Performance Status [Axis] Finite-lived intangible asset, useful life Finite-Lived Intangible Asset, Useful Life Estimated useful life CIK Entity Central Index Key Warrants [Member] Warrant [Member] Auditor Opinion [Text Block] Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Allowance for Doubtful Accounts, Premiums and Other Receivables Allowance for credit losses Less: Loss recognized in earnings on marketable equity securities sold Equity Securities, FV-NI, Realized Gain (Loss) Common stock, shares issued Common Stock, Shares, Issued Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Expected dividend yield [Member] Measurement Input, Expected Dividend Rate [Member] Cumulative translation adjustments Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Ending Balance Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax, Beginning Balance Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Schedule of Selected Quarterly Financial Information Quarterly Financial Information [Table Text Block] Preferred Shares Preferred Stock [Member] Upfront and Royalty payment Upfront And Royalty Payment Percentage Upfront and royalty payment percentage Income Statement [Abstract] Entity Address, State or Province Gain on transaction Business Combination, Separately Recognized Transactions, Net Gains and Losses Finance Lease, Liability, to be Paid, Year One 2025 Loss before net income tax benefit Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest LOSS BEFORE INCOME TAXES Event Based Development Milestones [Member] Event Based Development Milestones [Member] Lessee operating lease renewal term description Lessee Operating Leases Option To Extend Lessee operating leases option to extend. Deposits and other long-term assets Deposits And Other Longterm Assets Non Current Deposits and other longterm assets non current. Sublicensing fee percentage Sublicensing Fee Percentage. Loss Contingencies [Table] Proceeds from issuance of cash cash equivalents and marketable securities Proceeds From Issuance Of Cash Cash Equivalents And Marketable Securities Proceeds from issuance of cash cash equivalents and marketable securities. Accretion of income on marketable debt securities Accretion of income on marketable debt securities AccretionOfIncomeOnMarketableDebtSecurities Royalty payment percentage Royalty Payment Percentage. Marketable Securities Marketable Securities, Total Included within marketable securities Marketable debt securities ITI Collaboration Agreement [Member] ITI Collaboration Agreement [Member] Increase in shares authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Accrued interest and Penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total Aggregate Intrinsic Value, Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Liability Class [Axis] Schedule of Amortized Cost and Estimated Fair Value of Available-for-sale Debt Securities by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] 2012 Plan [Member] 2012 Plan [Member] Cover Cover [Abstract] Subsequent Event [Line Items] Operating Lease [Member] Operating Lease [Member] Basic net loss per share Earnings Per Share, Basic, Total Earnings Per Share, Basic Net loss per common share attributable to Lineage basic Es CellInternational Pte Ltd [Member] Es CellInternational Pte Ltd [Member] Fair Value, Assets and Liabilities Measured on Nonrecurring Basis, Valuation Techniques [Table Text Block] Summary of Significant Assumptions used in Valuing Warrant Liabilities Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Unrealized Gains Permanent differences Effective Income Tax Rate Reconciliation Permanent Differences Permanent differences OPERATING EXPENSES: Operating Expenses [Abstract] Financing cash flows from finance leases Repayment of finance lease liabilities Repayment of finance lease liabilities Finance Lease, Principal Payments Document Annual Report Pre-2018 [Member] Pre-2018. Investments, Debt and Equity Securities [Abstract] Alameda Lease [Member] Alameda Lease [Member] Sales related milestones Sales related milestones. AccountingStandardUpdate20140-9Member Accounting Standard Update2014-09 [Member] Accounting Standard Update2014-09 [Member] Total stock-based compensation expense Share-Based Payment Arrangement, Expense Weighted average discount rate Finance Lease, Weighted Average Discount Rate, Percent Common Stock Warrant Liability Recorded Under Registered Direct Finance Common Stock Warrant Liability Recorded Under Registered Direct Finance Common stock warrant liability recorded under registered direct financing Contingency withheld amount Contingency withheld amount. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit), Total Retained Earnings (Accumulated Deficit) Plan Name [Axis] Segment Reporting [Abstract] Number of Options Outstanding, Beginning balance Number of Options Outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number CURRENT ASSETS Assets, Current [Abstract] UNITED STATES [Member] Deferred Tax Liabilities, Net, Total Net deferred tax liabilities Deferred Tax Liabilities, Net Proceeds from the sale of HBL common shares Proceeds from the sale of common shares. Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Weighted Average Grant Date Fair Value Per Share, RSUs forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value CASH, CASH EQUIVALENTS AND RESTRICTED CASH: Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract] Number of Options Exercisable and Expected to Vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Adjustments of Operating Loss Carryforward Adjustments of operating loss carryforward. Reduction of operating loss carryforward Product and Service [Domain] Accumulated other comprehensive loss Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated Other Comprehensive Income (Loss), Net of Tax Tax Period [Domain] Operating loss carryforwards Operating Loss Carryforwards Total Property and equipment, net Property, Plant and Equipment, Net Property and equipment, net CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided by (Used in) Operating Activities [Abstract] Cantor Fitzgerald and Co Member [Member] Cantor Fitzgerald and Co Member [Member] 2017 Sales Agreement [Member] 2017 Sales Agreement [Member] Increased rent amount Increase in base rent amount. Schedule of Fair Value of Assets and Liabilities Valued on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Right-of-use assets - Finance Lease [Member] Finance Lease, Right Of Use Asset, Before Accumulated Amortization [Member] Finance lease, right of use asset, before accumulated amortization. Vesting [Axis] Other current liabilities Other finance lease liabilities current. OtherFinanceLeaseLiabilitiesCurrent Royalty Contracts [Member] Royalty Contracts [Member] Share-Based Payment Arrangement, Option [Member] Cybersecurity Risk Management Positions or Committees Responsible [Text Block] OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Unrealized gain on marketable debt securities Measurement Input Type [Domain] Deferred revenues - end of the period Total transaction price Contract with Customer, Liability, Total Contract with Customer, Liability Transaction price Deferred revenues - beginning of the year Accounts Receivable [Policy Text Block] Accounts Receivable, Net Statement of Cash Flows [Abstract] Upfront [Member] Upfront [Member] Israel Innovation Authority [Member] Israel Innovation Authority [Member] Antidilutive Securities, Name [Domain] Preferred stock, no par value Preferred Stock, No Par Value Litigation settlement amount Payments for Legal Settlements Class of warrant or right, number of securities called by warrants or rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of warrant or right, number All Entities Entity [Domain] Other Deferred Tax Assets, Other Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Equity Components [Axis] December 2022 Prospectus Supplement [Member] December Twenty Twenty Two Prospectus Supplement [Member] December 2022 prospectus supplement. Entity Address, Address Line One Accrued compensation Employee-related Liabilities, Current, Total Employee-related Liabilities, Current Number of RSUs Outstanding, RSUs granted Number of RSUs Outstanding, RSUs granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Number of restricted stock units, granted Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] Intangible Asset, Finite-Lived [Table] Lease commencement date Leases Commencement Date Lease commencement date. Property, Plant and Equipment [Line Items] Number Of Patients In Phase 1 Number of patients in phase 1. Number of patients in phase 1 Development And Commercial Milestones Across Multiple Indications [Member] Development and commercial milestones across multiple indications. Base rent increase rate This refer to base rent increase rate per year as per lease agreement. Subsequent Event Type [Axis] other income (expenses) Nonoperating Income (Expense) Total other income (expenses) Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Risk-free interest rates Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Change in right-of-use assets and liabilities Change in right-of-use assets and liabilities. Development [Member] Development [Member] Marketable Equity Securities Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Marketable Securities Number of RSUs Outstanding, Ending balance Number of RSUs Outstanding, Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Cell Cure Warrants [Member] Cell Cure Warrants [Member] Entity Voluntary Filers Subsidiary or Equity Method Investee [Line Items] Royalty percentage Royalty percentage. Royalty percentage Amendment Amendment Flag Operating Loss Carryforwards [Table] Net (income) loss attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest, Total Net Income (Loss) Attributable to Noncontrolling Interest Net loss attributable to noncontrolling interest Operating Lease, Liability, Noncurrent Right-of-use lease liabilities, noncurrent Operating lease liabilities, net of current portion Domestic Tax Jurisdiction [Member] Sale of Stock, Price Per Share Offering price Net loss attributable to Lineage NET LOSS ATTRIBUTABLE TO LINEAGE Lessee, Lease, Description [Table] February 2024 Registered Direct Offering February Twenty Twenty Four Registered Direct Offering [Member] February twenty twenty four registered direct offering. Operating Loss Carryforward Deductions Expiration Year Operating Loss Carryforward Deductions Expiration Year Operating loss carryforward deduction tax year Shares issued upon exercise of stock options, shares Number of Options Outstanding, Options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Number of Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Research and Development Expense [Member] Expenses related to safe harbor contribution Defined Contribution Plan, Cost Thousand Twenty Atlantic Premises [Member] Thousand Twenty Atlantic Premises [Member] Equity Component [Domain] Statistical Measurement [Domain] ATM Sales Agreement [Member] ATM Sales Agreement [Member] ATM Sales Agreement. Document Financial Statement Error Correction [Flag] General and administrative General and Administrative Expense, Total General and Administrative Expense Operating lease liability Deferred Tax Asset Operating Lease Liability Other Nonoperating Income (Expense), Total Other Nonoperating Income (Expense) Other income (expense), net Stock option Life Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] Disaggregation of Revenue [Table] Cybersecurity Risk Management Processes Integrated [Flag] NET LOSS Net Income (Loss), Including Portion Attributable to Noncontrolling Interest NET LOSS Net loss Current deferred revenue Deferred Revenue, Current Deferred Revenue, Current, Total Deferred revenues, current portion Preferred stock, shares issued Preferred Stock, Shares Issued Operating cash flows from operating leases Operating Lease, Payments Proceeds from employee options exercised Proceeds from Stock Options Exercised Sublicensing fee Sublicensing Fee Sublicensing Fee Common Share Warrant Liabilities [Member] Common share warrant liabilities. Warrant Liabilities [Member] Payables and Accruals [Abstract] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Industrial Microbes, Inc [Member] Industrial Microbes, Inc [Member] Operating Lease, Expense Operating lease expense Deferred Revenue, Noncurrent Deferred Revenue, Noncurrent, Total Deferred revenues, net of current portion Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Weighted Average Exercise Price of Options exercisable and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Upfront payment Amount of grants received Proceeds from Collaborators Restricted Cash, Noncurrent Restricted cash included in deposits and other long-term assets (see Note 13 (Commitments and Contingencies)) Collaborative Arrangement and Arrangement Other than Collaborative [Axis] January 2018 Lease [Member] January 2018 Lease [Member] COMPREHENSIVE LOSS ATTRIBUTABLE TO LINEAGE COMMON SHAREHOLDERS Comprehensive Income (Loss), Net of Tax, Attributable to Parent Common Stock, Shares, Outstanding, Beginning Balance Common stock, shares outstanding Common Stock, Shares, Outstanding, Ending Balance Common Stock, Shares, Outstanding Finite-Lived Intangible Assets, Major Class Name [Domain] Equity securities available for sale Amount reserved for future issuance Common Stock Capital Value Reserved For Future Issuance Common stock capital value reserved for future issuance. Ownership percentage Ownership percentage by parent Subsidiary, Ownership Percentage, Parent Antidilutive Securities [Axis] Accounts Receivable Net Current Excludes Scope Of ASU 2014 -09 Accounts receivable net current excludes scope of ASU 2014 -09. Accounts receivable, net - beginning of the year Accounts receivable, net - end of the period Tax credit carryforward limitations on use Tax Credit Carryforward, Limitations on Use Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Proceeds from sale of common shares with warrants Proceeds from Issuance or Sale of Equity Proceeds from Issuance or Sale of Equity, Total Finite-Lived Intangible Assets [Line Items] Intellectual Property [Member] Entity Interactive Data Current Estimated fair value, In one year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Lease expiration date Lease Expiration Date Marketable Securities [Table] Accounting Standards Update [Domain] Consolidated Entities [Axis] Marketable Securities [Table Text Block] Schedule of Marketable Equity Securities Weighted Average Grant Date Fair Value Per Share, RSUs Vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value At end of the period At beginning of the period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Related Party Transactions Related Party Transactions Disclosure [Text Block] Statement of Financial Position Location, Balance [Axis] Less imputed interest Finance Lease, Liability, Undiscounted Excess Amount Statistical Measurement [Axis] Research Tax Credit Carryforward [Member] Research and Development [Member] Maximum milestone payments to be received upon performance conditions Maximum milestone payments to be received upon performance conditions. Reductions related to settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Assets Assets, Fair Value Disclosure, Total Assets, Fair Value Disclosure Parent Company [Member] Schedule of Disaggregated Revenues Disaggregation of Revenue [Table Text Block] Schedule of Future Minimum Lease Commitments Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Operating cash flows from finance leases Finance Lease, Interest Payment on Liability Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Marketable Equity Securities [Member] Marketable Equity Securities [Member] Intangible assets subject to amortization Finite-Lived Intangible Assets, Gross Number of shares available for grant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Finance leases [Member] Financing Leases [Member] Financing Leases [Member] Weighted average grant-date fair value per share of RSUs granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Foreign Tax Jurisdiction [Member] Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Ownership [Domain] Statement of Income Location, Balance [Axis] Indefinite-Lived Intangible Assets [Line Items] Cash and Cash Equivalents [Axis] Reimbursements Cost Sharing Payments [Member] Reimbursements Cost Sharing Payments [Member] Investment owned balance, shares Investment Owned, Balance, Shares TOTAL ASSETS Assets Expected life (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Expected term (in years) Base rent and construction allowance per month Base rent and construction allowance per month. Tax Period [Axis] Deferred Tax Liabilities, Gross, Total Total deferred tax liabilities Deferred Tax Liabilities, Gross Number of RSUs Outstanding, RSUs vested Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted Entity Address, City or Town AOCI Attributable to Parent [Member] Accumulated Other Comprehensive Income / (Loss) [Member] Equity [Abstract] Auditor Location Payments for offering costs Payments of Stock Issuance Costs Stock issuance costs Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] Number of restricted stock units, forfeited Number of RSUs Outstanding, RSUs forfeited Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Finance Lease, Liability, to be Paid, Year Two 2026 Schedule of Stock Based Compensation Expense Share-Based Payment Arrangement, Cost by Plan [Table Text Block] Operating cash flows from finance leases Operating cash flows from financing leases. Warrant liabilities Derivative Liability, Noncurrent Weighted Average Remaining Contractual Team (Years), Options exercisable and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Loss contingency accrual, payments Loss Contingency Accrual, Payments Share price per share Share Price Amortized cost, In one year or less Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] Schedule of Share-based Compensation Activity Stock-Based Awards Share-Based Payment Arrangement [Text Block] Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] Legal fees related to reimbursable insurance policies Legal Fees Related to Reimbursable under Insurance Policies Legal fees related to reimbursable under insurance policies. Number of shares authorized for issuance Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Employees [Member] Employees [Member] Direct Financing [Member] Direct Financing . Direct Financing [Member] Safe harbour contribution, maximum contribution percentage Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Clinical development cost Clinical Development Cost Clinical development cost. Weighted average discount rate Operating Lease, Weighted Average Discount Rate, Percent Marketable securities, realized gain Marketable Securities, Realized Gain (Loss) Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration] Fair Value Disclosures [Abstract] Base monthly rent Base rent Refers to the base monthly rent as per lease agreement. Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Entity Public Float Unrealized loss recognized on marketable equity securities held at end of period, net Equity Securities, FV-NI, Unrealized Gain (Loss) Agreed signature fee amount Agreed signature fee amount. Weighted Average Exercise Price of Options Outstanding, Options expired/forfeited/cancelled Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan [Member] [Default Label] Royalties, license and other revenues [Member] Royalties, license and other revenues [Member] Royalties Member Stock Issued During Period, Value, New Issues Shares issued through registered direct financings Field of business description Field of business description. Deferred tax assets, net of valuation allowance Deferred Tax Assets, Net of Valuation Allowance Chief Executive Officer [Member] Shares issued upon exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Sales Agreement [Member] Sales Agreement [Member] Lessee, Lease, Description [Line Items] CURRENT LIABILITIES Liabilities, Current [Abstract] Lease Contractual Term [Axis] Cash and Cash Equivalents [Member] Document Type Document Type Schedule of Goodwill and Intangible Assets Net Schedule of Intangible Assets and Goodwill [Table Text Block] Accounting Standards Update [Axis] Corporate Credit Card Facility [Member] Corporate credit card facility. Corporate Credit Card Facility Impairment losses Asset Impairment Charges Asset Impairment Charges, Total Title of 12(b) Security Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value, Total Cash and Cash Equivalents, at Carrying Value Included within cash and cash equivalents Statement of Financial Position Location, Balance [Domain] Schedule of Supplemental Balance Sheet Information Related to Leases Lease, Cost [Table Text Block] Maximum percentage of milestone payments Maximum Percentage of Milestone Payments Maximum Percentage of Milestone Payments Cybersecurity Risk Management, Strategy, and Governance [Line Items] Statement of Stockholders' Equity [Abstract] Balance - December 31, 2023 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Balance - December 31, 2024 Document Fiscal Period Focus Derivative Liabilities Term Derivative liabilities term. Expected term Total intrinsic value of options exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value Research and development and other credits Deferred Tax Assets, Tax Credit Carryforwards, Research Research and development Research and Development Expense, Total Research and Development Expense Common shares received and retired for employee taxes paid Payment, Tax Withholding, Share-Based Payment Arrangement California [Member] CALIFORNIA Number of Options Outstanding, Options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross OncoCyte Corporation [Member] OncoCyte Corporation [Member] Indefinite-Lived Intangible Assets [Axis] Asset Class [Domain] Property and equipment, gross Property, Plant and Equipment, Gross, Ending Balance Property, Plant and Equipment, Gross, Beginning Balance Property, Plant and Equipment, Gross, Total Property, Plant and Equipment, Gross GBP [Member] GBP [Member] Insurance reimbursed amount Insurance Recoveries Subsequent Event Type [Domain] Finance leases, Right-of-use assets, net Finance leases, Right-of-use assets, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Leases Lessee, Leases [Policy Text Block] Measurement Input, Expected Term [Member] Expected Term [Member] Schedule of Weighted Average Assumptions to Calculate Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Warrant Liabilities [Member] Warrant liabilities. Number of buildings for lease Number of building for lease description. Payments for rent Payments for Rent Exercise price per share Class of Warrant or Right, Exercise Price of Warrants or Rights Financial Instruments [Domain] Financing Costs In Accounts Payable And Accrued Liabilities financing costs in accounts payable and accrued liabilities Financing costs in accounts payable and accrued liabilities Roche Agreement [Member] Roche Agreement [Member] NONCURRENT ASSETS Assets, Noncurrent [Abstract] Schedule of Composition of Lineage's Long-Lived Assets Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block] Sale of Stock [Axis] CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided by (Used in) Investing Activities [Abstract] Class of Warrant or Right, Date from which Warrants or Rights Exercisable Date of warrants exercisable Patents [Member] Money Market Funds, at Carrying Value Money market funds, at carrying value Lease modification Lease modification. 2012 Equity Incentive Plan and 2018 Inducement Option [Member] Two Thousand Twelve Equity Incentive Plan And Two Thousand Eighteen Inducement Option [Member] Two thousand twelve equity incentive plan and two thousand eighteen inducement option. Marketable debt securities Marketable securities Marketable Securities, Current Total revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Income Taxes Income Tax Disclosure [Text Block] Reductions for tax positions related to prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Weighted average price per share Weighted Average Price Per Share Weighted average price per share. Schedule of Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Cybersecurity Risk Management, Strategy, and Governance [Abstract] Ownership [Axis] Consolidated Entities [Domain] Credit Facility [Domain] ASU 2023-07 [Member] Accounting Standards Update 2023-07 [Member] Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Net, Ending Balance Finite-Lived Intangible Assets, Net, Beginning Balance Total intangible assets Cell Cure Neurosciences Ltd [Member] Cell Cure Neurosciences Ltd [Member] Depreciation and amortization expense Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation, Depletion and Amortization, Nonproduction Depreciation and amortization expense Subsidiary or Equity Method Investee, Sale of Stock [Table] Entity Address, Address Line Two LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities and Equity [Abstract] Period End Date Document Period End Date Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Rentable area Net Rentable Area ICFR Auditor Attestation Flag Income tax benefit (expense) Effective Income Tax Rate Reconciliation, Percent LONG-TERM LIABILITIES Liabilities, Noncurrent [Abstract] Cell Cure Neurosciences Lease [Member] Cell cure neurosciences lease. CCN Leases [Member] Deferred Tax Assets, Operating Loss Carryforwards, State and Local California taxable income Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Financing related fees Financing related fees. Net proceeds Sale of Stock, Consideration Received on Transaction Accrued liabilities Accrued Liabilities, Current, Total Accrued Liabilities, Current Deferred revenues - end of the period Deferred revenues - beginning of the period Deferred revenue Deferred Revenue, Total Deferred Revenue Deferred revenues Payment of financed insurance premium Payment of Financed Insurance Premium Payment of financed insurance premium. Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description Income tax expense Income Tax Expense (Benefit), Total Income Tax Expense (Benefit) Provision for income tax benefit 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan [Member] 2021 Equity Incentive Plan [Member] Trading Symbol Lineage's shareholders' equity Equity, Attributable to Parent, Ending Balance Equity, Attributable to Parent, Beginning Balance Equity, Attributable to Parent 1010 Atlantic Premises [Member] Thousand Ten Atlantic Premises [Member] Document Financial Statement Restatement Recovery Analysis [Flag] Total deferred tax assets Deferred Tax Assets, Gross Long-Lived Tangible Asset [Axis] Withholding tax Effective income tax rate reconciliation withholding tax. Stock-based Compensation Share-Based Payment Arrangement [Policy Text Block] Reconciliation of cash, cash equivalents and restricted cash, end of period: Reconciliation Of Cash Cash Equivalents And Restricted Cash End Of Period [Abstract] Reconciliation of cash cash equivalents and restricted cash end of period. Restricted Stock Units [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units (RSUs) [Member] Sale of stock Sale of Stock, Number of Shares Issued in Transaction Related Party Transactions [Abstract] Increase (Decrease) in Deferred Revenue Deferred revenue December 31, 2018 Exchange Rate [Member] December 31, 2018 Exchange Rate [Member] Property, Plant and Equipment [Table] Cybersecurity Risk Management, Strategy, and Governance [Table] Goodwill Goodwill Land subject to ground leases Land Subject to Ground Leases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Issued Accounting Standards Adoption Change in Accounting Principle, Accounting Standards Update, Adopted [true false] Loss on marketable equity securities, net Loss on marketable equity securities, net Loss on marketable equity securities, net Equity Securities, FV-NI, Gain (Loss) General and Administrative Expenses Selling, General and Administrative Expenses, Policy [Policy Text Block] Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Change in fair value of warrant liability recognized in the consolidated statement of operations Security deposit Security Deposit Measurement Input Type [Axis] Deferred tax benefit Deferred income tax benefit Deferred Income Tax Expense (Benefit) Deferred Income Tax Expense (Benefit), Total Geographical [Axis] Aggregate Intrinsic Value, Options exercisable and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Finance Lease, Liability, to be Paid, Year Three 2027 Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Unrealized Losses unrecognized compensation costs Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Prior Sales Agreement [Member] Prior Sales Agreement [Member] Prior sales agreement. Upfront licensing fees Upfront Licensing Fees. Upfront licensing fees Collaborative Arrangement [Member] Long-lived Intangible Assets Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Intangible Assets Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Measurement Input, Price Volatility [Member] Expected Stock Price Volatility [Member] Common stock unsold Common stock unsold. Sale of aggregate amount of stock Sale of aggregate amount of stock. Registered direct offering Registered Direct Offering [Member] Registered direct offering. Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend yield Schedule of Contract with Customer Contract Liability and Receivable Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Marketable Securities Marketable Securities, Policy [Policy Text Block] Security Exchange Name Operating Loss Carryforwards [Line Items] Fair Value by Liability Class [Domain] Equipment Furniture And Fixtures Member Equipment Furniture And Fixtures [Member] Measurement Input, Risk Free Interest Rate [Member] Risk-Free Interest Rate [Member] Additional right of use asset and lease liability Additional right of use asset and lease liability. Revenue recognized included in deferred revenue Revenue Recognized From Deferred Revenue At Beginning Of Period Revenue recognized from deferred revenue at beginning of period. Long-Lived Tangible Asset [Domain] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Legal Entity: Legal Entity [Axis] Fair Value Measurements Fair Value Disclosures [Text Block] Lessee, Operating Lease, Liability, to be Paid, Year Three 2027 Weighted average grant-date fair value per share of options granted Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Subsequent Event Subsequent Event [Member] Maximum [Member] Maximum [Member] TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity Oil and Gas, Full Cost Method, Capitalized Cost Excluded from Amortization, Development Cost, Period Cost Right-of-use assets, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Total SUPPLEMENTAL DISCLOSURES Supplemental Cash Flow Information [Abstract] Retirement Benefits [Abstract] Diluted net loss per share Earnings Per Share, Diluted Earnings Per Share, Diluted, Total Net loss per common share attributable to Lineage diluted Leasehold Improvements [Member] Weighted Average Price Per Share Issuance Of Common Stock Weighted average price per share issuance of common stock. Weighted average price per share issuance of common stock TOTAL LIABILITIES Liabilities Fair Value Hierarchy and NAV [Domain] Upfront license fees [Member] Upfront License Fees [Member] Upfront License Fees [Member] Total current assets Assets, Current Net Cash Provided by (Used in) Investing Activities Net cash (used in) provided by investing activities Operating loss carryforward expiration year Operating Loss Carryforward Expiration Year Operating loss carryforward expiration year. Collaboration Revenues [Member] Collaboration Revenues Member Collaboration Revenues [Member] Stock Issued During Period, Shares, New Issues Shares issued through registered direct financings, shares Balance at the end of the period Balance at the beginning of the period Unrecognized Tax Benefits Change in valuation allowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Option vested period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Roche Collaboration Agreement [Member] Roche Collaboration Agreement [Member] Entity Filer Category Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Foreign Currency Remeasurement, Gain (Loss), before Tax and Other Loss Foreign currency remeasurement, gain (loss), before tax and other loss. Foreign currency remeasurement and other loss Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Warrant exercisable into common share Total shareholders’ equity Balance Balance Equity, Including Portion Attributable to Noncontrolling Interest Organization, Basis of Presentation and Liquidity Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Purchases of marketable debt securities Payments to Acquire Marketable Securities OTHER INCOME (EXPENSES): Nonoperating Income (Expense) [Abstract] Schedule of Share-based Compensation Activity Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block] Current Fiscal Year End Date Insurance deductable Upfrount payment Payments for Advance to Affiliate SHAREHOLDERS' EQUITY Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Immunomic Therapeutics [Member] Immunomic Therapeutics [Member] Property and Equipment, Net Property, Plant and Equipment, Policy [Policy Text Block] Fair value of the options vested Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Noncontrolling Interest [Member] Noncontrolling Deficit [Member] Less imputed interest Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount B. Riley Securities, Inc. [Member] B. Riley Securities, Inc. [Member] B. Riley Securities, Inc. [Member] Finance leases, Right-of-use lease liabilities, current Finance Lease Liability Excluding Other Liabilities Current Finance lease liability excluding other liabilities current. Total stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense, Total Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Legal expenses Legal Fees Aggregate Intrinsic Value, Options Outstanding Aggregate Intrinsic Value, Options Outstanding, Ending Balance Aggregate Intrinsic Value, Options Outstanding, Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Registrant Name Entity Registrant Name Weighted average remaining lease term Finance Lease, Weighted Average Remaining Lease Term Indefinite-Lived Intangible Assets, Major Class Name [Domain] Financed insurance premium Increase (Decrease) In Financed Insurance Premium Increase (decrease) in financed insurance premium. Quarterly Financial Information [Text Block] Selected Quarterly Financial Information Number of equal annual installments Number of Equal Annual Installments Number of equal annual installments. Cost of sales Cost of Revenue, Total Cost of Revenue Cost of sales Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Right-of-use assets - Operating Lease [Member] Operating Lease, Right Of Use Asset, Before Accumulated Amortization [Member] Operating lease, right of use asset, before accumulated amortization. Entity Emerging Growth Company Upfront payment Upfront payment. Aggregate cash fee percentage Aggregate Cash Fee Percentage Aggregate cash fee percentage. Money Market Funds [Member] Other current liabilities Other Liabilities, Current Weighted Average Number of Shares Outstanding, Basic, Total Weighted Average Number of Shares Outstanding, Basic Weighted-average common shares used to compute net loss per common share, basic Vesting [Domain] Loss Contingencies [Line Items] Finance leases, Right-of-use lease liabilities, noncurrent Finance Lease, Liability, Noncurrent Finance lease liabilities, net of current portion Additions for tax positions related to prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions Accounting for Warrants [Policy Text Block] Accounting for warrants. Accounting for Warrants Interest income, net Interest Income (Expense), Nonoperating Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract] Common stock, shares authorized Common Stock, Shares Authorized Property, plant and equipment, useful life Property, Plant and Equipment, Useful Life Royalty [Member] Proceeds from Issuance of Common Stock Proceeds from issuance of common stock Proceeds from sale of common shares, net of offering costs Proceeds from the sale of marketable equity securities Proceeds from Sale and Maturity of Marketable Securities Cash and Cash Equivalents [Abstract] Fair Value, Inputs, Level 1 [Member] Clinical regulatory milestone Clinical regulatory milestone. Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued liabilities Stock-based compensation Adjustments To Common Stock Share Based Compensation Requisite Service Period Recognition Value Adjustments to common stock share based compensation requisite service period recognition value. Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Weighted Average Exercise Price of Options Outstanding, Options granted Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Amortization of intangible assets Amortization of Intangible Assets Deferred Compensation Arrangement with Individual, Excluding Share-Based Payment and Postretirement Benefit [Table] Financial Instrument [Axis] NIS [Member] NIS [Member] Weighted Average Remaining Contractual Team (Years),Options Outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Basic and Diluted Net Income (Loss) per Share Attributable to Common Shareholders Earnings Per Share, Policy [Policy Text Block] General and Administrative Expense [Member] Share-Based Payment Arrangement [Abstract] Impairment of Long-lived Assets Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Hadasit Medical Research Services and Development Ltd [Member] Hadasit Medical Research Services And Development Ltd [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Capitalized research expense Deferred tax asset capitalized research expense. Debt Securities [Member] Debt Securities [Member] At the Market [Member] At the market . ATM [Member] Proceeds from sale of common shares with warrants under registered direct financing, net of offering costs Proceeds from Issuance of Warrants Aggregate gross proceeds Cybersecurity Risk Role of Management [Text Block] Fair Value of Warrant Liability Recognized upon Issuance in Registered Direct Financing Fair value of warrant liability recognized upon issuance in registered direct financing. Fair value of warrant liability recognized upon issuance in registered direct financing Lineage's available-for-sale debt securities Debt Securities, Available-for-Sale Estimated fair value, Total available-for-sale debt securities Fair Value Accounting Policies [Abstract] Schedule of Collaboration Agreements Collaboration Agreements [Table Text Block] Cash and Cash Equivalents [Line Items] Income Tax Disclosure [Abstract] Additions for tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Gross proceeds from issuance of common stock Gross Proceeds from Sale of Common Stock Gross Proceeds from Sale of Common Stock Gross proceeds from issuance of common stock Gross Proceeds from Issuance of Common Stock Gross proceeds from issuance of common stock. Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Statement [Table] Revenue Recognition from Collaborative Agreements [Policy Text Block] Revenue recognition from collaborative agreements. Revenue Recognition from Collaborative Agreements Schedule of Property and Equipment, Net Property, Plant and Equipment [Table Text Block] Less: Comprehensive (income) loss attributable to noncontrolling interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Subsequent Event [Table] Preferred stock, shares authorized Preferred Stock, Shares Authorized Fair Value Adjustment of Warrants Change in fair value of warrant liability Fair value of warrant liabilities Change in fair value of warrant liability Total revenues under collaborative agreements Revenue from Contract with Customer, Including Assessed Tax Collaboration revenues Entity File Number Segment Reporting Disclosure [Text Block] Segment Information Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect NET INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH Revenue from Contract with Customer [Abstract] Cash Equivalents [Member] Cash Equivalents [Member] Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Upfront payment Loss Contingency, Receivable, Proceeds State tax benefit Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State tax benefit Lease Contractual Term [Domain] Statement of Financial Position [Abstract] Tax Credit Carryforward [Axis] Second Performance Obligation [Member] Second performance obligation. Operating Income (Loss) Loss from operations Loss from operations Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Common stock, no par value Common Stock, No Par Value Entity Shell Company Purchase obligation Purchase Obligation Purchase Obligation, Total Entity Tax Identification Number Transactions with Noncontrolling Interests of Subsidiaries Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block] ASSETS Assets [Abstract] Disclosure Enterprisewide Disclosures Abstract Enterprise-wide Disclosures Entity Current Reporting Status Weighted Average Remaining Contractual Team (Years),Options exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Maximum Aggregate Number of Common Shares Offering Under Agreement Maximum aggregate number of common shares offering under agreement. Maximum aggregate number of common shares offering under agreement Schedule of Accounts Payable and Accrued Liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Deferred tax liabilities operating lease right of use assets. DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets Operating lease ROU assets Subsequent Events [Abstract] Cash and cash equivalents and marketable securities Cash And Cash Equivalents And MarketableSecurities. Geographical [Domain] Document Fiscal Year Focus Effective Date Change in Accounting Principle, Accounting Standards Update, Adoption Date Expected convertion to revenue by 2026 Expected Convertion to Revenue by 2026 Expected convertion to revenue by 2026. RSUs Vest On or Prior to Each of Second and Third anniversaries of Such Date [Member] Share-Based Payment Arrangement, Tranche Two [Member] Second Tranche [Member] Preferred Stock, Value, Issued Preferred shares, no par value, 2,000 shares authorized; none issued and outstanding as of December 31, 2024 and 2023 Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Total Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Number of Options Outstanding, Options expired/forfeited/cancelled Broadwood Partners, L.P [Member] Broadwood Partners, L.P [Member] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Schedule of Unrecognized Tax Benefits Roll Forward Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Tax credit carryforward amount Tax Credit Carryforward, Amount City Area Code 2012 and 2018 Equity Incentive Plan 2012 and 2018 Equity Incentive Plan [Member] 2012 and 2018 Equity Incentive Plan [Member] Warrants and Rights Outstanding, Measurement Input Expected dividend yield Total current liabilities Liabilities, Current Revenue Recognition from Royalties, License and Other Revenues Revenue Recognition from Royalties, License and Other Revenues [Policy Text Block] Revenue recognition from royalties, license and other revenues. Equity Securities [Member] Equity Securities [Member] Computed tax benefit at federal statutory rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Employee Benefit Plan Defined Contribution Plan [Text Block] Goodwill and IPR&D Goodwill and Intangible Assets, Policy [Policy Text Block] Pay costs percentage Pay costs percentage. Issuance Costs For Common Stock Warrant Liabilities Issuance costs for common stock warrant liabilities. Issuance costs for common stock warrant liabilities Organization, Consolidation and Presentation of Financial Statements [Abstract] Local Phone Number Preferred stock, shares outstanding Preferred Stock, Shares Outstanding, Ending Balance Preferred Stock, Shares Outstanding, Beginning Balance Preferred Stock, Shares Outstanding Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Income Tax Jurisdiction [Axis] Financial Instrument Performance Status [Domain] Upfront payment percentage Upfront Payment Percentage Upfront Payment Percentage Income Taxes Income Tax, Policy [Policy Text Block] Schedule of Income before Income Tax, Domestic and Foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Neal Bradsher [Member] Neal Bradsher [Member] Amortized cost Debt Securities, Available-for-Sale, Amortized Cost Amortized cost, Total available-for-sale debt securities Amortized Cost Schedule of Components of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Operating Lease, Liability, Current Right-of-use lease liabilities, current Operating lease liabilities, current portion Finance leases Right-of-Use Asset Obtained in Exchange for Finance Lease Liability In Process Research and Development [Member] Comprehensive loss foreign currency translation adjustments, net of tax Foreign currency translation gain Foreign currency translation adjustment Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Total Income Tax Jurisdiction [Domain] Retained Earnings [Member] Accumulated Deficit [Member] Prepaid Expenses and Other Current Assets [Member] Prepaid Expenses and Other Current Assets [Member] Purchase of equipment Payments to Acquire Property, Plant, and Equipment, Total Payments to Acquire Property, Plant, and Equipment Upfont payment received Upfront payment received Upfront payment received. Document Transition Report Number of restricted stock units to be vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options to be Vested In Period Share based compensation arrangement by share based payment award equity instruments other than options to be vested in period. Enterprise-Wide Disclosures Enterprise Wide Disclosures [Text Block] Lessee, Operating Lease, Liability, to be Paid, Year Two Rent for remaining twelve months 2026 Antidilutive Security, Excluded EPS Calculation [Table] Weighted Average Exercise Price of Options, Options exercised Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentrations of Credit Risk, Significant Sources of Supply, and Significant Customers Auditor Firm ID Minimum [Member] Common Shares Common Stock [Member] Deposit assets Restricted cash Restricted Cash Restricted Cash, Total Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accounts Payable and Accrued Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Reimbursements [Member] Reimbursements [Member] Investment, Name [Axis] Weighted Average Grant Date Fair Value Per Share, Ending balance Weighted Average Grant Date Fair Value Per Share, Beginning balance Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value IPR&D - OPC1 [Member] IPR&D - OPC1 [Member] Entity Well-known Seasoned Issuer Foreign Currency Translation Adjustments, Other Comprehensive Income or Loss and Foreign Currency Transaction Gains and Losses Foreign Currency Transactions and Translations Policy [Policy Text Block] Office and Laboratory Space, Jerusalem, Israel [Member] Office and Laboratory Space, Jerusalem, Israel [Member] Net proceeds Amount reserved for future issuance Common Stock Capital Value Maximum Authorized Shares Available For Future Issuance Common stock capital value maximum authorized shares available for future issuance. Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss attributable to Lineage Cell Therapeutics, Inc. to net cash used in operating activities: Sublease agreement option to extend Lessee, Operating Sublease, Option to Extend Other comprehensive loss, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Statement of Income Location, Balance [Domain] Lessee, Operating Lease, Liability, to be Paid, Year One Rent for first twelve months 2025 HBL HBL [Member] HBL. Goodwill and Intangible Assets Disclosure [Abstract] Entity Common Stock, Shares Outstanding Foreign Member Foreign [Member] Disaggregation of Revenue [Line Items] Schedule of Supplemental Cash Flow Information Related to Leases Schedule of supplemental cash flow information related to leases [Table Text Block] GILTI inclusion GILTI inclusion Effective Income Tax Rate Reconciliation, GILTI, Percent Schedule of Revenues from External Customers and Long-Lived Assets [Table] Noncontrolling deficit Noncontrolling deficit Equity, Attributable to Noncontrolling Interest, Ending Balance Equity, Attributable to Noncontrolling Interest, Beginning Balance Equity, Attributable to Noncontrolling Interest, Total Equity, Attributable to Noncontrolling Interest Unamortized balance of acquired royalty contracts Finite-Lived Intangible Asset, Expected Amortization, Year One Title and Position [Domain] Cell Cure Leases [Member] Cell cure leases. Segment Reporting, Expense Information Used by CODM, Description Finance leases, Right-of-use lease liabilities, current Finance Lease, Liability, Current Finance lease liabilities, current portion Finance leases, Right-of-use assets Finance Lease, Right-of-Use Asset, before Accumulated Amortization Common Stock, Value, Issued Common shares, no par value, 450,000 shares authorized as of December 31, 2024 and 2023; 220,416 and 174,987 shares issued and outstanding as of December 31, 2024 and 2023, respectively Marketable Debt Securities [Member] Marketable Debt Securities [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Amortization expense for right-of-use finance lease assets Finance Lease, Right-of-Use Asset, Amortization Schedule of Intangible Assets Future Amortization Expenses Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Aggregate cap amount Aggregate Cap Amount. Cash and Cash Equivalent [Table] Insurers [Member] Insurers [Member] Carlsbad Lease [Member] Carlsbad Lease [Member] Total operating lease liabilities Total operating lease liabilities Operating Lease, Liability Total Summary of Available for Sale Debt Securities Debt Securities, Available-for-Sale [Table Text Block] Don M. Bailey [Member] Don M. Bailey. Net operating loss carryforwards Deferred Tax Assets, Operating Loss Carryforwards, Total Deferred Tax Assets, Operating Loss Carryforwards Commitments and Contingencies Commitments and contingencies (Note 13) Marketable Securities [Line Items] Insurance recovery receivable Loss Contingency, Receivable Loss Contingency, Receivable, Ending Balance Loss Contingency, Receivable, Beginning Balance Loss Contingency, Receivable, Total Settlement Agreement [Member] Settlement Agreement [Member] Weighted Average Number of Shares Outstanding, Diluted Weighted Average Number of Shares Outstanding, Diluted, Total Weighted-average common shares used to compute net loss per common share, diluted Significant Accounting Policies Significant Accounting Policies [Text Block] Accounts receivable, net - end of the period Accounts receivable, net - beginning of the period Accounts receivables amounted Accounts Receivable, after Allowance for Credit Loss, Current Accounts Receivable, after Allowance for Credit Loss, Current, Total Accounts receivable, net Asterias Equity Plan [Member] Asterias Equity Plan [Member] Total lease payments Total lease payments Lessee, Operating Lease, Liability, to be Paid Cybersecurity Risk Management Third Party Engaged [Flag] Insurance deductable Insurance deductable. Budgetary commitment amount Budgetary commitment. Total Total finance lease liabilities Finance Lease, Liability COMPREHENSIVE LOSS Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Entity Small Business Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block] IPR&D - VAC2 [Member] IPR&D - VAC2 [Member] Percentage of commission payable Refers to a commission payable to the seller as a percentage of gross proceeds from the sale of shares of the entity. Intangible Asset, Indefinite-Lived [Table] Immunomic Therapeutics Inc [Member] Immunomic Therapeutics Inc [Member] Schedule of Lineage's Ownership of Outstanding Shares of its Subsidiaries Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Table Text Block] Deferred tax assets, operating loss carryforwards, domestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic Schedule Of Securities Owned Readily Marketable [Table Text Block] Securities owned readily marketable. Schedule of Fair Value of Marketable Securities Intangibles Deferred Tax Liabilities, Intangible Assets Revenues Total revenues Total revenues Revenues Agreements Abstract Agreements Abstract US Treasury Securities [Member] Foreign currency remeasurement and other loss Gain (Loss), Foreign Currency Transaction, before Tax Gain (Loss), Foreign Currency Transaction, before Tax, Total Foreign currency transaction loss, net Revenues from External Customers and Long-Lived Assets [Line Items] Credit Facility [Axis] Carlsbad Sub Lease [Member] Carlsbad Sub Lease [Member] Shares issued upon vesting of restricted stock units, net of shares retired to pay employees' taxes, shares Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures, Total Post-2017 [Member] Post-2017. CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided by (Used in) Financing Activities [Abstract] Weighted Average Exercise Price of Options Outstanding, Beginning balance Weighted Average Exercise Price of Options Outstanding, Ending balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Asset Class [Axis] Number of patients in phase 1/2a Number Of Patients In Phase 1/2a Number of patients in phase 1/2a. Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Agreements With Hadasit and IIA [Member] Agreements With Hadasit And I I A [Member] Agreements With Hadasit And I I A. State and Local Jurisdiction [Member] Operating leases Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Measurement period adjustment income tax expense benefit Measurement period adjustment income tax expense benefit. Valuation allowance Deferred Tax Assets, Valuation Allowance Fair Value, Inputs, Level 3 [Member] Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Subsequent Events Subsequent Events [Text Block] Grants awarded percentage Grants Awarded Percentage. Quarterly Financial Information Disclosure [Abstract] Unrealized gain (loss) on marketable debt securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax, Total Cybersecurity Risk Management Positions or Committees Responsible [Flag] Accounts payable Accounts Payable, Current, Total Accounts Payable, Current Alameda Sublease [Member] Alameda Sublease [Member] Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false] Costs and Expenses Total operating expenses Liabilities Liabilities, Fair Value Disclosure, Total Liabilities, Fair Value Disclosure Fair value of warrant liabilities Marketable securities at fair value Deferred Tax Liabilities, Investment in Noncontrolled Affiliates Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Total